FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020631337> ?p ?o ?g. }

• W2020631337 endingPage "129" @default.
• W2020631337 startingPage "123" @default.
• W2020631337 abstract "Targeted therapies are emerging as important drugs in the treatment of advanced non-small cell lung cancer (NSCLC). Within the past months, there have been considerable contributions to this topic. The results of several important clinical trials have been published. Furthermore, laboratory results have significantly contributed to clear out some molecular mechanisms regulating sensitivity or resistance to these drugs and to provide rational basis for further clinical studies.A great part of recently published research on targeted agents in NSCLC regards EGFR inhibitors. Following the demonstration of activity of gefitinib in patients pretreated with chemotherapy, four large randomized trials testing the addition of gefitinib or erlotinib to first-line chemotherapy have been conducted, but failed to show any advantage. Interestingly, erlotinib has shown efficacy compared with placebo in pretreated patients. Mutations in the EGFR gene have shown a strong predictive role for sensitivity to EGFR inhibitors. A number of other targeted agents are currently under investigation: most of the phase II trials maintain a traditional methodology, with response rate as primary measure of activity.Recent advances will lead to a rapid expansion of further studies aimed to define the best way to use targeted agents in NSCLC. Several methodological issues are still open. The proper selection of patients, the choice of the best study design and the most appropriate end-point for early clinical trials, and the correct modality to integrate these drugs with traditional chemotherapy represent the most challenging points that research is called to answer in the near future." @default.
• W2020631337 created "2016-06-24" @default.
• W2020631337 creator A5003014678 @default.
• W2020631337 creator A5007575010 @default.
• W2020631337 creator A5015740152 @default.
• W2020631337 creator A5035710316 @default.
• W2020631337 date "2005-03-01" @default.
• W2020631337 modified "2023-10-09" @default.
• W2020631337 title "Targeted therapies and non-small cell lung cancer: methodological and conceptual challenge for clinical trials" @default.
• W2020631337 cites W1787102412 @default.
• W2020631337 cites W1980791428 @default.
• W2020631337 cites W1997159039 @default.
• W2020631337 cites W2016710415 @default.
• W2020631337 cites W2023584100 @default.
• W2020631337 cites W2043696829 @default.
• W2020631337 cites W2049484790 @default.
• W2020631337 cites W2053146576 @default.
• W2020631337 cites W2067653691 @default.
• W2020631337 cites W2100785570 @default.
• W2020631337 cites W2106066245 @default.
• W2020631337 cites W2108947370 @default.
• W2020631337 cites W2110835998 @default.
• W2020631337 cites W2111710483 @default.
• W2020631337 cites W2120718661 @default.
• W2020631337 cites W2125776292 @default.
• W2020631337 cites W2127101185 @default.
• W2020631337 cites W2127788151 @default.
• W2020631337 cites W2128373232 @default.
• W2020631337 cites W2136174670 @default.
• W2020631337 cites W2139236349 @default.
• W2020631337 cites W2146404049 @default.
• W2020631337 cites W2147352197 @default.
• W2020631337 cites W2160999558 @default.
• W2020631337 cites W2161821474 @default.
• W2020631337 cites W2162638402 @default.
• W2020631337 cites W2167241562 @default.
• W2020631337 cites W2169724454 @default.
• W2020631337 cites W2171342364 @default.
• W2020631337 cites W2325726156 @default.
• W2020631337 doi "https://doi.org/10.1097/01.cco.0000155048.51919.eb" @default.
• W2020631337 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15725916" @default.
• W2020631337 hasPublicationYear "2005" @default.
• W2020631337 type Work @default.
• W2020631337 sameAs 2020631337 @default.
• W2020631337 citedByCount "8" @default.
• W2020631337 countsByYear W20206313372012 @default.
• W2020631337 crossrefType "journal-article" @default.
• W2020631337 hasAuthorship W2020631337A5003014678 @default.
• W2020631337 hasAuthorship W2020631337A5007575010 @default.
• W2020631337 hasAuthorship W2020631337A5015740152 @default.
• W2020631337 hasAuthorship W2020631337A5035710316 @default.
• W2020631337 hasConcept C121608353 @default.
• W2020631337 hasConcept C126322002 @default.
• W2020631337 hasConcept C143998085 @default.
• W2020631337 hasConcept C177713679 @default.
• W2020631337 hasConcept C2776256026 @default.
• W2020631337 hasConcept C2777506169 @default.
• W2020631337 hasConcept C2778087573 @default.
• W2020631337 hasConcept C2779438470 @default.
• W2020631337 hasConcept C2780580887 @default.
• W2020631337 hasConcept C2781230642 @default.
• W2020631337 hasConcept C32220436 @default.
• W2020631337 hasConcept C535046627 @default.
• W2020631337 hasConcept C60644358 @default.
• W2020631337 hasConcept C71924100 @default.
• W2020631337 hasConcept C86803240 @default.
• W2020631337 hasConceptScore W2020631337C121608353 @default.
• W2020631337 hasConceptScore W2020631337C126322002 @default.
• W2020631337 hasConceptScore W2020631337C143998085 @default.
• W2020631337 hasConceptScore W2020631337C177713679 @default.
• W2020631337 hasConceptScore W2020631337C2776256026 @default.
• W2020631337 hasConceptScore W2020631337C2777506169 @default.
• W2020631337 hasConceptScore W2020631337C2778087573 @default.
• W2020631337 hasConceptScore W2020631337C2779438470 @default.
• W2020631337 hasConceptScore W2020631337C2780580887 @default.
• W2020631337 hasConceptScore W2020631337C2781230642 @default.
• W2020631337 hasConceptScore W2020631337C32220436 @default.
• W2020631337 hasConceptScore W2020631337C535046627 @default.
• W2020631337 hasConceptScore W2020631337C60644358 @default.
• W2020631337 hasConceptScore W2020631337C71924100 @default.
• W2020631337 hasConceptScore W2020631337C86803240 @default.
• W2020631337 hasIssue "2" @default.
• W2020631337 hasLocation W20206313371 @default.
• W2020631337 hasLocation W20206313372 @default.
• W2020631337 hasOpenAccess W2020631337 @default.
• W2020631337 hasPrimaryLocation W20206313371 @default.
• W2020631337 hasRelatedWork W1991551364 @default.
• W2020631337 hasRelatedWork W2015104488 @default.
• W2020631337 hasRelatedWork W2134157108 @default.
• W2020631337 hasRelatedWork W2184487997 @default.
• W2020631337 hasRelatedWork W2254126652 @default.
• W2020631337 hasRelatedWork W2280113021 @default.
• W2020631337 hasRelatedWork W2348666640 @default.
• W2020631337 hasRelatedWork W2363852307 @default.
• W2020631337 hasRelatedWork W2418692205 @default.
• W2020631337 hasRelatedWork W3147989365 @default.
• W2020631337 hasVolume "17" @default.
• W2020631337 isParatext "false" @default.

• next